Objectives This study aimed to evaluate the fear of infection among Egyptian dentists practicing during the current coronavirus disease 2019 (COVID-19) pandemic and to explore the dentist’s knowledge about guidelines to fight the virus and to assess various modifications in dental practice. Methods An online survey was submitted to dental professionals. Data were collected through a validated questionnaire consisting of 23 closed-ended questions. The gathered data were statistically analyzed. Results An overall 216 dentists completed the survey. A total of 200 (92.6%) dental professionals were afraid of becoming infected with COVID-19 while 196 (90.7%) became anxious to treat patients showing suspicious symptoms. The majority of the participants were aware of the mode of transmission of COVID-19 and a lot of them were updated with the current Disease Control and Prevention (CDC) or World Health Organization (WHO) guidelines for cross-infection control. Conclusions COVID-19 pandemic has a significant impact on dental professionals.
Objectives The goal of the current study was to evaluate the relative frequency of oral and maxillofacial pathological lesions among Egyptian children. Materials and methods Records of biopsies submitted to the department of oral and maxillofacial pathology from the year 1999 to 2019 were retrieved and reassessed for all cases under the age of 18 years. Information on age, sex, location of the lesion, and the histopathologic diagnosis was analyzed. Results Over the course of twenty-one years, 1108 specimens were analyzed where reactive soft tissue lesions, which accounted for 397 (35.8%) of all cases ranked the highest presented category, followed by inflammatory odontogenic cysts, which accounted for 213 cases (19.2%). With 208 cases, the inflammatory radicular cyst was on the top of the most common 20 lesions, followed by pyogenic granuloma (160 cases). Malignancy was found in 19 cases, with soft tissue tumors (10 cases) being the most common, followed by salivary gland (5 cases) and bone pathologies (4 cases). Conclusions The frequency of oral and maxillofacial pathological lesions among Egyptian children increased over the years but remained consistent with global trends. Clinical relevance This is the first study evaluating the relative frequency of oral and maxillofacial pathological lesions among Egyptian children and provides an insight into the most commonly encountered pediatric pathologies. This may aid in the understanding of the most prevalent oral lesions that impact the pediatric population, as well as providing the key to early detection of lesions.
Background The use of antibiotics in dentistry as prophylaxis and treatment is frequent. Their misuse has led to a major public health problem globally known as antibiotic resistance. This study aimed to assess the pattern of antibiotic prescription and its prophylactic use for systemic conditions. Besides, this study evaluated the awareness and adherence to antibiotic prescription guidelines and antibiotic prophylaxis guidelines along with awareness of antibiotic resistance across pediatric and general dentists. Methods An overall of 378 pediatric and general dentists meeting the required eligibility criteria, fulfilled a pre-designed validated questionnaire. Data were collected, tabulated, and statistically analyzed. Results A significant statistical difference was found among the pediatric and general dentists regarding antibiotics prescription for most of the oral conditions where Amoxicillin with clavulanic acid was the most frequently prescribed antibiotic among the two groups (53% pediatric dentist and 52% general dentist). The majority of pediatric and general dentists, on the other hand, were aware of antibiotic resistance and prescribing recommendations. Conclusions The present study showed a tendency to overprescribe and overuse antibiotics in certain dental conditions among the participants. The vast majority of dentists, especially general dentists do not have adherence to professional guidelines for antibiotics prescription in children despite their awareness of antibiotic resistance and prescription guidelines.
Aim: This study aimed to evaluate the anaesthetic efficacy of 4% Alexadricaine versus 2% Mepecaine-L for infiltration anaesthesia in the extraction of maxillary first primary molars in children. Subjects and Methods:The present study is a split-mouth study in which ten children aged from 5 to 7 years with bilateral badly decayed maxillary first primary molars indicated for extraction were selected from the outpatient diagnostic clinic in Pediatric Dentistry and Dental Public Health Department, Faculty of Dentistry, Cairo University. The children's teeth were randomly assigned to two groups. Group A received 4% Alexadricaine and group B received 2% Mepecaine-L for infiltration anaesthesia. The intra-operative pain during the extraction was assessed using the Visual Analogue Scale (VAS) and the Sound, Eyes and Motor Scale (SEM). Moreover, the onset and duration of soft tissue anaesthesia were objectively evaluated. Results: Group A showed slightly higher values of VAS and SEM scale than group B regarding intra-operative pain during extraction with a statistically non-significant difference. Regarding the onset of soft tissue anaesthesia, both groups had the same mean value (0.25±0.00). Regarding the duration of soft tissue anaesthesia, group A (214.00±9.66 minutes) showed a significantly higher mean value than group B (162.50±16.87 minutes) with a statistically significant difference (P<0.001). Conclusion:Regarding infiltration anaesthesia in the extraction of maxillary first primary molars in children, both 4% Alexadricaine and 2% Mepecaine-L can provide similar effective pain control with rapid onset of action. However, 4% Alexadricaine has a longer duration of soft tissue numbness than 2% Mepecaine-L.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.